GALVUS 50 mg, tablet 30 tablets
Active ingredients: Vildagliptin
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GALVUS 50 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) polyamide aluminium PVC de 30 comprimé(s)
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- 15 %
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>traitement du diabète de type 2 :<br>- En bithérapie, en association avec la metformine ou un sulfamide hypoglycémiant<br>- En trithérapie orale, en association avec un sulfamide hypoglycémiant et la metformine ; JOURNAL OFFICIEL ; 24/07/15
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Sept 2009
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67520378CIP73819516CIP133400938195163Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VILDAGLIPTINEcomprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.